Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or best available therapy: Response trial results

Authors
Category Primary study
JournalBlood
Year 2014
This article has no abstract
Epistemonikos ID: 3c73afb195bf715d848107446c2eaab4418dab3d
First added on: Feb 06, 2025